Projects per year
Personal profile
Monash teaching commitment
HUP3011 - Human pathology: Atherosclerosis
HUP3011 - Human pathology: Vascular biology and disease
IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy
Central Clinical School Honours program "Molecular Imaging Technology"
Biography
Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.
Education/Academic qualification
Chemistry, PhD, University of Freiburg
Chemistry, MSc, University of Freiburg
External positions
NHMRC Senior Research Fellow, National Health & Medical Research Council (NHMRC)
1 Jan 2019 → 31 Dec 2023A/Prof, RMIT University
1 Mar 2014 → …Keywords
- PET CT
- acute MI
- animal models of human disease
- antibodies
- arterial thrombosis
- drug delivery systems
- microbubbles
- molecular imaging
- platelets
- thrombosis
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2023
A national Magnetic Particle Imaging Facility
Egan, G., Davis, T., Hagemeyer, C., O'Brien, T., Martino, M., Bansal, V. & Crosbie, J.
7/02/19 → 31/12/19
Project: Research
Thrombin Responsive Nanoparticles for Prophylaxis and Treatment of Acute Thrombosis
6/08/18 → 5/02/22
Project: Research
Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
Hagemeyer, C. & Caruso, F.
National Health & Medical Research Council (NHMRC)
1/01/18 → 31/12/21
Project: Research
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
Hagemeyer, C. & McMullen, J.
National Health & Medical Research Council (NHMRC)
1/07/17 → 30/06/20
Project: Research
Research Output 1999 2019
Carbohydrates@MOFs
Astria, E., Thonhofer, M., Ricco, R., Liang, W., Chemelli, A., Tarzia, A., Alt, K., Hagemeyer, C. E., Rattenberger, J., Schroettner, H., Wrodnigg, T., Amenitsch, H., Huang, D. M., Doonan, C. J. & Falcaro, P., 1 Jun 2019, In : Materials Horizons. 6, 5, p. 969-977 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Development of a novel peptide tracer for detection of cardiac fibrosis and atrial fibrillation using mouse models of cardiomyopathies
Niego, B., Alt, K., Noor, A., How, O. J., Du, X-J., Donnelly, P. S., McMullen, J. & Hagemeyer, C., 9 Jul 2019.Research output: Contribution to conference › Abstract › Other › peer-review
Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine
Hashad, R. A., Lange, J. L., Tan, N. C. W., Alt, K. & Hagemeyer, C. E., 2019, Bioconjugation : Methods in Molecular Biology. Massa, S. & Devoogdt, N. (eds.). New York, NY: Humana Press, p. 67-80 14 p. (Methods in Molecular Biology; vol. 2033).Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review
Functional Brush Poly(2-ethyl-2-oxazine)s: Synthesis by CROP and RAFT, Thermoresponsiveness and Grafting onto Iron Oxide Nanoparticles
Klein, T., Parkin, J., de Jongh, P. A. J. M., Esser, L., Sepehrizadeh, T., Zheng, G., De Veer, M., Alt, K., Hagemeyer, C. E., Haddleton, D. M., Davis, T. P., Thelakkat, M. & Kempe, K., May 2019, In : Macromolecular Rapid Communications. 40, 10, 6 p., 1800911.Research output: Contribution to journal › Article › Research › peer-review
Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake
Cui, J., Alt, K., Ju, Y., Gunawan, S. T., Braunger, J. A., Wang, T. Y., Dai, Y., Dai, Q., Richardson, J. J., Guo, J., Björnmalm, M., Hagemeyer, C. E. & Caruso, F., 9 Sep 2019, In : Biomacromolecules. 20, 9, p. 3592-3600 9 p.Research output: Contribution to journal › Article › Research › peer-review
Activities 2013 2014
- 2 Editorial responsibility
Cardiovascular Therapeutics (Journal)
Christoph Hagemeyer (Associate editor)2014 → …
Activity: Publication peer-review and editorial work types › Editorial responsibility
PLoS ONE (Journal)
Christoph Hagemeyer (Associate editor)2013 → …
Activity: Publication peer-review and editorial work types › Editorial responsibility